PRO overlap statistics ranged from 0.52 to 0.59 and from 0.60 to 0.70 for randomly selected patients with high versus medium and low BSA, respectively, indicating patients with high and medium BSA are likely to have similar levels of disease burden, and patients with high BSA are slightly more likely to have higher disease burden than those with low BSA
More serious risks include: Low blood sugar (hypoglycemia): Especially when used with other medicines to treat diabetes, low blood sugar may occur, with symptoms such as dizziness, sweating, blurred vision, or confusion
Colon-Soto, M., Peredo, R
Needleless technology significantly diminishes these events, making the treatment process safer for everyone involved
Supplements like those offered by TrimRx (GLP-1 Daily Support and Weight Loss Boost) can complement your transition off medication by supporting metabolic health and reducing cravings
Promotion of hair regrowth and thickness